• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺苷受体激动剂在肝硬化肝切除模型中的保护作用

Protective Effects of Adenosine Receptor Agonist in a Cirrhotic Liver Resection Model.

作者信息

Iskandarov Emil, Kadaba Srinivasan Pramod, Xin Wang, Bleilevens Christian, Afify Mamdouh, Hamza Astrit, Wei Lai, Hata Koichiro, Agayev Boyukkishi, Tolba Rene

机构信息

Department of Hepato-biliary and Pancreas Surgery, Scientific Center of Surgery named after academician M.A.Topchubashov, Baku, Azerbaijan.

Institute for Laboratory Animal Science and Experimental Surgery, University Hospital, RWTH Aachen University, Aachen, Germany.

出版信息

Hepat Mon. 2016 Jul 24;16(8):e36821. doi: 10.5812/hepatmon.36821. eCollection 2016 Aug.

DOI:10.5812/hepatmon.36821
PMID:27799962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5075226/
Abstract

OBJECTIVES

To investigate the role of CGS21680, a selective adenosine A2A receptor agonist, on a bile-duct-ligated cirrhotic liver resection model in rats.

METHODS

Male Wistar rats were allotted into 3 groups (n = 7 per time-point): the control group, the bile duct ligation + CGS21680 group (BDL + CGS), and the bile duct ligation group (BDL). Biliary cirrhosis had been previously induced by ligature of the common bile duct in the BDL + CGS and BDL groups. After 2 weeks, the animals underwent partial hepatectomy (50%). The BDL + CGS group received a single dose of CGS21680 15 minutes prior to hepatectomy. Blood samples were collected and analyzed.

RESULTS

Aspartate transaminase levels were found to be lower in the control vs BDL groups (1, 3, and 24 h) (P < 0.01) and the BDL + CGS (1 and 3 hours) (P < 0.01) and BDL + CGS vs BDL (24 hours) (P < 0.05) groups. Hepatic flow was measured and BDL showed significantly lower values at the 3, 24, and 168 h time-points compared to the control (P < 0.01) and BDL + CGS groups (P < 0.05 at 3 and 168 hours; P < 0.01 at 24 h). O2C velocity was reduced in the BDL compared to the control group (P < 0.001 at 3 hours; P < 0.01 at 24 and 168 hours) and the BDL + CGS group (P < 0.01 at 24 hours). Interleukin-6 levels were abrogated in the BDL + CGS (P < 0.05) and control (P < 0.01) groups versus BDL. Histone-bound low-molecular-weight DNA fragments in the BDL + CGS (P < 0.01) and control (P < 0.05) groups were low compared to the BDL group.

CONCLUSIONS

Administration of CGS21680, an adenosine receptor agonist, after the resection of bile-duct-ligated cirrhotic livers led to improved liver function, regeneration, and microcirculation.

摘要

目的

研究选择性腺苷A2A受体激动剂CGS21680在大鼠胆管结扎性肝硬化肝切除模型中的作用。

方法

将雄性Wistar大鼠分为3组(每个时间点n = 7):对照组、胆管结扎+CGS21680组(BDL + CGS)和胆管结扎组(BDL)。BDL + CGS组和BDL组先前已通过结扎胆总管诱导了胆汁性肝硬化。2周后,动物接受部分肝切除术(50%)。BDL + CGS组在肝切除术前15分钟接受单剂量的CGS21680。采集血样并进行分析。

结果

发现对照组与BDL组(1、3和24小时)以及BDL + CGS组(1和3小时)相比,天冬氨酸转氨酶水平较低(P < 0.01),且BDL + CGS组与BDL组(24小时)相比(P < 0.05)。测量肝血流量,与对照组(P < 0.01)和BDL + CGS组(3和168小时时P < 0.05;24小时时P < 0.01)相比,BDL组在3、24和168小时时间点的值显著较低。与对照组(3小时时P < 0.001;24和168小时时P < 0.01)和BDL + CGS组(24小时时P < 0.01)相比,BDL组的氧摄取率降低。与BDL组相比,BDL + CGS组(P < 0.05)和对照组(P < 0.01)的白细胞介素-6水平降低。与BDL组相比,BDL + CGS组(P < 0.01)和对照组(P < 0.05)中组蛋白结合的低分子量DNA片段较少。

结论

在胆管结扎性肝硬化肝脏切除术后给予腺苷受体激动剂CGS21680可改善肝功能、肝脏再生和微循环。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/5075226/afe0a0fd5ebe/hepatmon-16-08-36821-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/5075226/0f6d2cdfaa10/hepatmon-16-08-36821-i001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/5075226/60de1722b991/hepatmon-16-08-36821-i002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/5075226/0ba73fa0bc8c/hepatmon-16-08-36821-i003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/5075226/fcce1df92593/hepatmon-16-08-36821-i004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/5075226/d04cdacb7307/hepatmon-16-08-36821-i005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/5075226/afe0a0fd5ebe/hepatmon-16-08-36821-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/5075226/0f6d2cdfaa10/hepatmon-16-08-36821-i001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/5075226/60de1722b991/hepatmon-16-08-36821-i002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/5075226/0ba73fa0bc8c/hepatmon-16-08-36821-i003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/5075226/fcce1df92593/hepatmon-16-08-36821-i004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/5075226/d04cdacb7307/hepatmon-16-08-36821-i005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/5075226/afe0a0fd5ebe/hepatmon-16-08-36821-g001.jpg

相似文献

1
Protective Effects of Adenosine Receptor Agonist in a Cirrhotic Liver Resection Model.腺苷受体激动剂在肝硬化肝切除模型中的保护作用
Hepat Mon. 2016 Jul 24;16(8):e36821. doi: 10.5812/hepatmon.36821. eCollection 2016 Aug.
2
Gut-liver axis improves with meloxicam treatment after cirrhotic liver resection.肝硬化肝切除术后使用美洛昔康治疗可改善肠-肝轴。
World J Gastroenterol. 2014 Oct 28;20(40):14841-54. doi: 10.3748/wjg.v20.i40.14841.
3
The Impact of a Nitric Oxide Synthase Inhibitor (L-NAME) on Ischemia⁻Reperfusion Injury of Cholestatic Livers by Pringle Maneuver and Liver Resection after Bile Duct Ligation in Rats.一氧化氮合酶抑制剂(L-NAME)对胆系阻断后普雷格尔(Pringle)手法肝缺血再灌注损伤及肝切除大鼠肝脏的影响。
Int J Mol Sci. 2019 Apr 29;20(9):2114. doi: 10.3390/ijms20092114.
4
Effects of Myrtus communis extract treatment in bile duct ligated rats.香桃木提取物治疗对胆管结扎大鼠的影响。
J Surg Res. 2016 Oct;205(2):359-367. doi: 10.1016/j.jss.2016.06.094. Epub 2016 Jul 5.
5
Inhibition of hepatic tumour necrosis factor-alpha attenuates the anandamide-induced vasoconstrictive response in cirrhotic rat livers.抑制肝脏肿瘤坏死因子-α可减弱花生四烯酸乙醇胺诱导的肝硬化大鼠肝脏血管收缩反应。
Liver Int. 2009 May;29(5):678-85. doi: 10.1111/j.1478-3231.2009.01983.x.
6
Curcumin attenuates hepatic fibrosis and insulin resistance induced by bile duct ligation in rats.姜黄素可减轻胆管结扎诱导的大鼠肝纤维化和胰岛素抵抗。
Br J Nutr. 2018 Aug;120(4):393-403. doi: 10.1017/S0007114518001095. Epub 2018 Jun 8.
7
[Inhibitory effect of angiotensin blockade on hepatic fibrosis in common bile duct-ligated rats].[血管紧张素阻断对胆总管结扎大鼠肝纤维化的抑制作用]
Korean J Hepatol. 2007 Mar;13(1):61-9.
8
Rat renal function four days after bile-duct ligation: effects of indomethacin and vasoactive agents.胆管结扎术后四天大鼠的肾功能:吲哚美辛和血管活性药物的作用
Ren Fail. 2002 Mar;24(2):111-26. doi: 10.1081/jdi-120004089.
9
The NF-kappaB inhibitors attenuate hepatic injury in bile duct ligated rats.核因子-κB抑制剂可减轻胆管结扎大鼠的肝损伤。
Pediatr Surg Int. 2006 Aug;22(8):655-63. doi: 10.1007/s00383-006-1721-9. Epub 2006 Jul 8.
10
Increased sensitivity to endotoxemia in the bile duct-ligated cirrhotic Rat.胆管结扎肝硬化大鼠对内毒素血症的敏感性增加。
Hepatology. 1999 Nov;30(5):1198-205. doi: 10.1002/hep.510300515.

引用本文的文献

1
Adenosine A2a Receptor Stimulation Attenuates Ischemia-Reperfusion Injury and Improves Survival in A Porcine Model of DCD Liver Transplantation.腺苷 A2a 受体刺激可减轻缺血再灌注损伤并提高 DCD 肝移植猪模型的存活率。
Int J Mol Sci. 2020 Sep 14;21(18):6747. doi: 10.3390/ijms21186747.
2
Purinergic Signalling: Therapeutic Developments.嘌呤能信号传导:治疗进展
Front Pharmacol. 2017 Sep 25;8:661. doi: 10.3389/fphar.2017.00661. eCollection 2017.

本文引用的文献

1
Silymarin and hepatocellular carcinoma: a systematic, comprehensive, and critical review.水飞蓟素与肝细胞癌:一项系统、全面且批判性的综述
Anticancer Drugs. 2015 Jun;26(5):475-86. doi: 10.1097/CAD.0000000000000211.
2
Gut-liver axis improves with meloxicam treatment after cirrhotic liver resection.肝硬化肝切除术后使用美洛昔康治疗可改善肠-肝轴。
World J Gastroenterol. 2014 Oct 28;20(40):14841-54. doi: 10.3748/wjg.v20.i40.14841.
3
Mouse hepatocytes and LSEC proteome reveal novel mechanisms of ischemia/reperfusion damage and protection by A2aR stimulation.
小鼠肝细胞和 LSEC 蛋白质组揭示了 A2aR 刺激对缺血/再灌注损伤和保护的新机制。
J Hepatol. 2015 Mar;62(3):573-80. doi: 10.1016/j.jhep.2014.10.007. Epub 2014 Oct 12.
4
Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis.1980年至2010年间187个国家的肝硬化死亡率:一项系统分析。
BMC Med. 2014 Sep 18;12:145. doi: 10.1186/s12916-014-0145-y.
5
Pathogenesis of liver cirrhosis.肝硬化的发病机制。
World J Gastroenterol. 2014 Jun 21;20(23):7312-24. doi: 10.3748/wjg.v20.i23.7312.
6
The burden of liver disease in Europe: a review of available epidemiological data.欧洲的肝脏疾病负担:现有流行病学数据综述。
J Hepatol. 2013 Mar;58(3):593-608. doi: 10.1016/j.jhep.2012.12.005.
7
Ischaemia-reperfusion injury in liver transplantation--from bench to bedside.肝移植中的缺血再灌注损伤——从基础到临床。
Nat Rev Gastroenterol Hepatol. 2013 Feb;10(2):79-89. doi: 10.1038/nrgastro.2012.225. Epub 2012 Dec 11.
8
Hepatocellular carcinoma in cirrhotic patients with portal hypertension: is liver resection always contraindicated?肝硬化伴门静脉高压症患者的肝细胞癌:肝切除术是否总是禁忌?
World J Gastroenterol. 2011 Dec 14;17(46):5083-8. doi: 10.3748/wjg.v17.i46.5083.
9
Pharmacological postconditioning protects against hepatic ischemia/reperfusion injury.药物后处理可防止肝脏缺血/再灌注损伤。
Liver Transpl. 2011 Apr;17(4):474-82. doi: 10.1002/lt.22256.
10
Current protective strategies in liver surgery.当前肝脏外科手术中的保护策略。
World J Gastroenterol. 2010 Dec 28;16(48):6098-103. doi: 10.3748/wjg.v16.i48.6098.